This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Alexandre Ambrogelly
Introduction
Alexandre Ambrogelly is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work has implications for various therapeutic applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Ambrogelly holds a patent for FLT3L-Fc fusion proteins. This patent includes polynucleotides encoding such fusion proteins, expression cassettes, vectors, cells, and kits comprising these fusion proteins. The methods of using these proteins are also outlined in his patent, highlighting their potential in medical treatments.
Career Highlights
Ambrogelly is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
He has collaborated with notable colleagues, including Manuel Baca and Brian A. Carr. These partnerships enhance the research environment and contribute to the advancement of their collective work in biotechnology.
Conclusion
Alexandre Ambrogelly's contributions to the field of biotechnology through his patent on FLT3L-Fc fusion proteins exemplify the importance of innovation in healthcare. His work at Gilead Sciences, Inc. and collaborations with esteemed colleagues further underscore his impact in this vital area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile